LEUCI, Valeria
 Distribuzione geografica
Continente #
NA - Nord America 2.102
AS - Asia 1.323
EU - Europa 1.060
SA - Sud America 139
AF - Africa 26
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.665
Nazione #
US - Stati Uniti d'America 2.053
SG - Singapore 505
IT - Italia 440
CN - Cina 377
VN - Vietnam 164
BR - Brasile 105
FI - Finlandia 102
DE - Germania 94
IE - Irlanda 83
SE - Svezia 72
FR - Francia 67
KR - Corea 49
HK - Hong Kong 46
IN - India 46
GB - Regno Unito 40
NL - Olanda 32
PL - Polonia 32
CA - Canada 31
JP - Giappone 25
UA - Ucraina 25
ID - Indonesia 21
TW - Taiwan 17
ES - Italia 16
IQ - Iraq 14
MX - Messico 14
AR - Argentina 13
BD - Bangladesh 13
AU - Australia 12
TR - Turchia 12
AT - Austria 11
ZA - Sudafrica 9
CH - Svizzera 8
TH - Thailandia 8
EC - Ecuador 7
RU - Federazione Russa 6
BE - Belgio 5
NO - Norvegia 5
PT - Portogallo 5
BA - Bosnia-Erzegovina 4
DZ - Algeria 4
PK - Pakistan 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CO - Colombia 3
DK - Danimarca 3
HU - Ungheria 3
TN - Tunisia 3
UY - Uruguay 3
CL - Cile 2
EG - Egitto 2
GA - Gabon 2
IR - Iran 2
JM - Giamaica 2
JO - Giordania 2
LT - Lituania 2
MA - Marocco 2
NZ - Nuova Zelanda 2
PH - Filippine 2
RO - Romania 2
UZ - Uzbekistan 2
AO - Angola 1
BH - Bahrain 1
BY - Bielorussia 1
DJ - Gibuti 1
DM - Dominica 1
EU - Europa 1
HN - Honduras 1
IL - Israele 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
PS - Palestinian Territory 1
PY - Paraguay 1
RS - Serbia 1
SN - Senegal 1
TG - Togo 1
Totale 4.665
Città #
Singapore 331
Ashburn 245
Chandler 171
Beijing 141
Turin 114
San Jose 113
Fairfield 99
Santa Clara 95
Houston 90
Dublin 83
Torino 61
Helsinki 58
Seattle 52
Woodbridge 50
The Dalles 46
Ho Chi Minh City 40
Jacksonville 39
Los Angeles 36
Dallas 35
Seoul 34
Wilmington 34
Nyköping 33
Hanoi 32
Hong Kong 32
Munich 32
New York 32
Milan 31
Hefei 30
Ann Arbor 28
Dong Ket 27
Lauterbourg 27
Cambridge 25
Columbus 25
Shanghai 24
Warsaw 24
Guangzhou 22
Pisa 22
Medford 20
Boardman 19
Fremont 19
Princeton 19
Tokyo 19
Villeurbanne 18
Council Bluffs 17
Dearborn 17
Buffalo 16
Jakarta 16
Turku 16
Washington 15
Bengaluru 13
Boston 11
Montreal 11
Nanjing 11
São Paulo 11
Taipei 11
San Diego 10
Brooklyn 9
Chicago 9
Mexico City 9
Nuremberg 9
Pieve Emanuele 9
Lappeenranta 8
Naples 8
Phoenix 8
Silver Spring 8
Stockholm 8
Amsterdam 7
Haiphong 7
Hangzhou 7
Johannesburg 7
Kunming 7
Orem 7
Pune 7
Wuhan 7
Denver 6
Detroit 6
Florence 6
Frankfurt am Main 6
Mumbai 6
Redondo Beach 6
Rome 6
San Francisco 6
Wroclaw 6
A Coruña 5
Atlanta 5
Birmingham 5
London 5
Manchester 5
Sydney 5
Toronto 5
Xian 5
Baghdad 4
Barcelona 4
Belo Horizonte 4
Bern 4
Biên Hòa 4
Da Nang 4
Düsseldorf 4
Falkenstein 4
Falls Church 4
Totale 2.973
Nome #
Cytokine Induced Killer cells kill chemo-surviving melanoma cancer stem cells 462
BRAF and MEK inhibitors increase PD1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti-PD1 antibody 333
Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapy 217
Cytokine-induced killer (CIK) cells as feasible and effective adoptive immunotherapy for the treatment of solid tumors. 213
CD44v6 as innovative sarcoma target for CAR-redirected CIK cells 212
Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity 206
CAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive Immunotherapy 206
Novel lymphocyte-independent antitumor activity by PD-1 blocking antibody against PD-1+ chemoresistant lung cancer cells 201
Cytokine Induced Killer cells effectively kill chemo-resistant melanoma cancer stem cells. 201
CSPG4-specific CAR.CIK lymphocytes as a novel therapy for the treatment of multiple soft tissue sarcoma histotypes 194
Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy 181
Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective 156
Ex Vivo Allogeneic Stimulation Significantly Improves Expansion of Cytokine-Induced Killer Cells Without Increasing Their Alloreactivity Across HLA Barriers. 152
Epha2 expression in bone sarcomas: Bioinformatic analyses and preclinical characterization in patient-derived models of osteosarcoma, ewing’s sarcoma and chondrosarcoma 144
Effective Activity of Cytokine Induced Killer Cells against Autologous Metastatic Melanoma including Cells with Stemness Features. 143
Adoptive immunotherapy against sarcomas. 142
Efficient transcriptional targeting of human hematopoietic stem cells and blood cell lineages by lentiviral vectors containing the regulatory element of the Wiskott-Aldrich Syndrome gene 141
CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma 133
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST 129
Gene-modified T lymphocytes in the setting of hematopoietic cell transplantation: potential benefits and possible risks. 129
Parp1 inhibitor and trabectedin combination does not increase tumor mutational burden in advanced sarcomas—a preclinical and translational study 125
Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplification 124
Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis 116
Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti-leukaemic potential and alloreactivity across major human leukocyte antigen barriers 113
Abstract 3998: Preclinical efficacy of a synthetic Notch-based combinatorial immunotherapy against colorectal cancer with HER2 amplification 113
Transient proteasome inhibition as a strategy to enhance lentiviral transduction of hematopoietic CD34(+) cells and T lymphocytes: implications for the use of low viral doses and large-size vectors. 105
PD-1 receptor outside the main paradigm: tumour-intrinsic role and clinical implications for checkpoint blockade 84
The cGAS-STING pathway is a master regulator of OCT4 expression in persistent sarcoma cells and enhances cellular immunotherapy with NK and CIK lymphocytes 68
Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translation 44
Totale 4.787
Categoria #
all - tutte 15.268
article - articoli 0
book - libri 0
conference - conferenze 981
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.249


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202185 0 0 0 0 0 0 0 0 0 0 24 61
2021/2022312 15 27 10 11 10 15 25 18 8 32 90 51
2022/2023535 35 42 6 63 41 122 34 46 76 17 37 16
2023/2024312 32 48 25 15 20 58 21 15 1 12 31 34
2024/2025850 17 44 57 63 155 68 25 72 66 91 92 100
2025/20261.698 211 82 94 260 256 89 276 78 168 128 56 0
Totale 4.787